Abstract
Markovian regulatory networks constitute a class of discrete state-space models used to study gene regulatory dynamics and discover methods that beneficially alter those dynamics. Thereby, this class of models provides a framework to discover effective drug targets and design potent therapeutic strategies. The salient translational goal is to design therapeutic strategies that desirably modify network dynamics via external signals that vary the expressions of a control gene. The objective of an intervention strategy is to reduce the likelihood of the pathological cellular function related to a disease. The task of finding an effective intervention strategy can be formulated as a sequential decision making problem for a pre-defined cost of intervention and a cost-per-stage function that discriminates the gene-activity profiles. An effective intervention strategy prescribes the actions associated with an external signal that result in the minimum expected cost. This strategy in turn can be used as a treatment that reduces the long-run likelihood of gene expressions favorable to the disease. In this tutorial, we briefly summarize the first method proposed to design such therapeutic interventions, and then move on to some of the recent refinements that have been proposed. Each of these recent intervention methods is motivated by practical or analytical considerations. The presentation of the key ideas is facilitated with the help of two case studies.
Keywords: Regulatory networks, markovian decision processes, translational genomics, systems biology
Current Genomics
Title: Recent Advances in Intervention in Markovian Regulatory Networks
Volume: 10 Issue: 7
Author(s): Babak Faryabi, Golnaz Vahedi, Aniruddha Datta, Jean-Francois Chamberland and Edward R. Dougherty
Affiliation:
Keywords: Regulatory networks, markovian decision processes, translational genomics, systems biology
Abstract: Markovian regulatory networks constitute a class of discrete state-space models used to study gene regulatory dynamics and discover methods that beneficially alter those dynamics. Thereby, this class of models provides a framework to discover effective drug targets and design potent therapeutic strategies. The salient translational goal is to design therapeutic strategies that desirably modify network dynamics via external signals that vary the expressions of a control gene. The objective of an intervention strategy is to reduce the likelihood of the pathological cellular function related to a disease. The task of finding an effective intervention strategy can be formulated as a sequential decision making problem for a pre-defined cost of intervention and a cost-per-stage function that discriminates the gene-activity profiles. An effective intervention strategy prescribes the actions associated with an external signal that result in the minimum expected cost. This strategy in turn can be used as a treatment that reduces the long-run likelihood of gene expressions favorable to the disease. In this tutorial, we briefly summarize the first method proposed to design such therapeutic interventions, and then move on to some of the recent refinements that have been proposed. Each of these recent intervention methods is motivated by practical or analytical considerations. The presentation of the key ideas is facilitated with the help of two case studies.
Export Options
About this article
Cite this article as:
Faryabi Babak, Vahedi Golnaz, Datta Aniruddha, Chamberland Jean-Francois and Dougherty R. Edward, Recent Advances in Intervention in Markovian Regulatory Networks, Current Genomics 2009; 10 (7) . https://dx.doi.org/10.2174/138920209789208246
DOI https://dx.doi.org/10.2174/138920209789208246 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
Current Molecular Imaging (Discontinued) An Arylidene-Thiazolidinedione Derivative, GPU-4, without PPARγ Activation, Reduces Retinal Neovascularization
Current Neurovascular Research Prevention of Neointimal Hyperplasia by Local Application of Lentiviral Vectors Encoding Pin1 shRNA in Pluronic F127
Current Gene Therapy Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Current Drug Targets New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry The Regulation of Neuroimmune-Endocrine Interactions: Mechanisms,Molecular Pathways Unraveled and the Pivotal Role of Cytokines – A Unsung Putative Bidirectional Interdependence between the Immune and Neuroendocrine Interfaces
Current Immunology Reviews (Discontinued) The Therapeutic Potential of ADAM15
Current Pharmaceutical Design Nanoparticles vs Cancer: A Multifuncional Tool
Current Topics in Medicinal Chemistry GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease
CNS & Neurological Disorders - Drug Targets Targeted Drug Delivery Systems and Their Therapeutic Applications in Cancer and Immune Pathological Conditions
Infectious Disorders - Drug Targets Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Signaling by Reactive Oxygen and Nitrogen Species in Skin Diseases
Current Drug Metabolism CDK Inhibitors Induce Mitochondria-mediated Apoptosis Through the Activation of Polyamine Catabolic Pathway in LNCaP, DU145 and PC3 Prostate Cancer Cells
Current Pharmaceutical Design Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Garcinia Benzophenones Inhibit the Growth of Human Colon Cancer Cells and Synergize with Sulindac Sulfide and Turmeric
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide in Physiological and Pathological Mechanisms in Brain
CNS & Neurological Disorders - Drug Targets Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model
Current Vascular Pharmacology Pharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
Current Medicinal Chemistry